TITLE

Vancomycin-Intermediate Staphylococcus aureus with Phenotypic Susceptibility to Methicillin in a Patient with Recurrent Bacteremia

AUTHOR(S)
Naimi, Timothy S.; Anderson, Daniel; O'Boyle, Carol; Boxrud, David J.; Johnson, Susan J.; Tenover, Fred C.; Lynfield, Ruth
PUB. DATE
June 2003
SOURCE
Clinical Infectious Diseases;6/15/2003, Vol. 36 Issue 12, p1609
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Vancomycin-intermediate Staphylococcus aureus (VISA) are an emerging problem. We observed a statistically significant inverse relationship in the MICs of vancomycin and oxacillin in S. aureus isolates from a patient undergoing hemodialysis who received 26 weeks of treatment with vancomycin during November 1999 through April 2000. All isolates were mecA positive and were indistinguishable by pulsed-field gel electrophoresis. The evolving susceptibility patterns of this strain highlight the challenges of detecting and treating VISA infections.
ACCESSION #
10024060

 

Related Articles

  • Role of High Vancomycin Minimum Inhibitory Concentration in the Outcome of Methicillin-Susceptible Staphylococcus aureus Bacteremia. Aguado, José M.; San-Juan, Rafael; Fernández-Ruiz, Mario; Chaves, Fernando // Journal of Infectious Diseases;3/15/2012, Vol. 205 Issue 6, p1024 

    A letter to the editor is presented in response to the article "Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations" by N.E. Holmes, J.D. Turnidge and W.J. Munckhof in a of the journal.

  • Daptomycin and vancomycin of similar value in MRSA infection.  // PharmacoEconomics & Outcomes News;12/1/2007, Issue 542, p4 

    The article focuses on the findings of a study on the cost effectiveness of daptomycin and vancomycin for treating patients with meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia and/or endocarditis. The researchers collected data for 45 daptomycin and 44 vancomycin recipients from a...

  • Current adult vancomycin dosing recommendations inadequate for treating children with MRSA.  // Infectious Diseases in Children;Jun2009, Vol. 22 Issue 6, p16 

    The article discusses research being done on the efficacy of vancomycin for children with methicillin-resistant Staphylococcus aureus infections, by A. Frymoyer, published in the 2009 issue of the "Pediatric Infectious Disease Journal."

  • Vancomycin.  // Reactions Weekly;7/24/2010, Issue 1311, p42 

    The article describes the case of a man who developed anaphylaxis while receiving treatment with vancomycin for a meticillin-resistant Staphylococcus aureus (MRSA) infection.

  • In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies. Gallon, O.; Guillet-Caruba, C.; Lamy, B.; Laurent, F.; Doucet-Populaire, F.; Decousser, J.-W. // European Journal of Clinical Microbiology & Infectious Diseases;Oct2009, Vol. 28 Issue 10, p1209 

    Staphylococci are a leading cause of skin and soft tissue infections (SSTIs) and bacteremia in France, a country with a high prevalence of oxacillin resistance. We evaluated the in vitro activity of daptomycin compared with reference compounds against 445 Staphylococcus aureus and 53...

  • Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility. Howden, Benjamin P.; Ward, Peter B.; Charles, Patrick C. P.; Korman, Tony M.; Fuller, Andrew; du Cros, Philipp; Grabsch, Elizabeth A.; Roberts, Sally A.; Robson, Jenny; Read, Kerry; Bak, Narin; Hurley, James; Johnson, Paul D. R.; Morris, Arthur J.; Mayall, Barrie C.; Grayson, M. Lindsay // Clinical Infectious Diseases;2/15/2004, Vol. 38 Issue 4, p521 

    Although infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (SA-RVS) have been reported from a number of countries, including Australia, the optimal therapy is unknown. We reviewed the clinical features, therapy, and outcome of 25 patients...

  • Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001–07. Reynolds, R.; Hope, R.; Warner, M.; MacGowan, A. P.; Livermore, D. M.; Ellington, M. J. // Journal of Antimicrobial Chemotherapy (JAC);Dec2012, Vol. 67 Issue 12, p2912 

    Objectives There have been several reports of upward creep in vancomycin MICs for Staphylococcus aureus [predominantly methicillin-resistant S. aureus (MRSA)] over recent years, but only in single centres or using contemporaneous results. We aimed to test the hypothesis of MIC creep in a...

  • Short-Course Therapy of Catheter-related Staphylococcus aureus Bacteremia: A Meta-analysis. Jernigan, John A.; Farr, Barry M. // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p304 

    Presents information on a study that examined the effectiveness of short-course antibiotic therapy for catheter-related Staphylococcus aureus bacteremia through structured methodologic review of published articles. Nature and timing of late complications after short-course therapy; Clinical...

  • Occult Staphylococcus aureus Bacteremia: Other Points to Consider. Nannini, Esteban C.; Arias, Cesar A. // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 11, p1679 

    A letter to the editor is presented in response to an article related to the comparison of Staphylococcus aureus bacteremia with patients admitted in hospitals by Chia-Ming Fu et al in the previous issue of the journal.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics